Details of issuance or disposal
Exercise of the Series 16 Stock Acquisition Rights issued through a third-party allotment (with an option to revise the exercise price)
83,000 new shares
The lower thin line represents the existing number of shares to which these shares will be added.
Approximately 0.99% (83,000 shares ÷ 8,394,800 shares outstanding at the end of the previous month)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | Exercise of the Series 16 Stock Acquisition Rights issued through a third-party allotment (with an option to revise the exercise price) |
| Number of shares to be issued or disposed of | 83,000 new shares |
| Intended allottee | Cantor Fitzgerald Europe (issued on 26 December 2025) |
| Dilution Rate | Approximately 0.99% (83,000 shares ÷ 8,394,800 shares outstanding at the end of the previous month) |
| Total number of issued shares | 8,394,800 shares → 8,477,800 shares（Approximately 0.99%） |
| Exercise price | ¥764 (2 April 2026). The floor under the adjustment provision is Not disclosed |
| Number of Stock Acquisition Rights | Total issued: 6,515 rights; unexercised as of the end of the previous month: 6,172 rights; currently unexercised: 5,342 rights |
| Most recent equity financing | Timing 26 December 2025 / Type Third-party allotment of the 16th Stock Acquisition Rights (with an option to revise the exercise price) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To announce the substantial exercise of these stock acquisition rights on 2 April 2026.